Updated List of Prebiotics/Probiotics Companies and Investors
Posted 22nd October 2018 by Jane Williams
The Probiotics/Prebiotics Market
Interest in microbiota, specifically in human health and disease, has encouraged consumers to focus on digestive health, which has seen the probiotics and prebiotics market go from strength-to-strength.
As a result, the global probiotics and prebiotics market was valued at approximately USD 40.09 billion in 2017 and is expected to generate revenue of around USD 65.87 billion by end of 2024, growing at a compound annual growth rate of around 7.35% between 2018 and 2024. 
We’ve compiled a list of 69 prebiotics and probiotics companies and investors that have been active between 2015 and 2018. Here are some of the companies that have received the most investments:
Thryve is the world’s first gut health company that incorporates microbiome testing with personalised dietary and probiotic recommendations.
A privately held biopharmaceutical company based in Tokyo, Japan. Anaeropharma Science was established in 2004 to pioneer the development of novel therapeutics to target such a hypoxic environment in solid cancers based on its proprietary platform technology, i-DPS, utilising recombinant bifidobacterium.
Scioto is a preclinical stage company developing innovative therapies devoted to having a transformative impact on the delivery of microbiome therapeutics.
To find out more, download the list. Whether you’re just curious or are looking for an investor from seed to series, you’re sure to find something useful.
There will be plenty of opportunities to network with and hear from probiotic/prebiotic experts, industry leaders and investors at the Probiotics & Prebiotics Congress: USA.
Leave a Reply